Biotechnology Assets S.A. (BST) — Cash Flow-to-Debt Ratio
Biotechnology Assets S.A. (BST) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2025, meaning its operating cash flow of €658.13K could theoretically repay 0% of its total liabilities (€7.01 Million) in one year. See how financially flexible is Biotechnology Assets S.A. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biotechnology Assets S.A. Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Biotechnology Assets S.A. across 11 annual periods. For the full cash flow conversion analysis, see Biotechnology Assets S.A. cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Biotechnology Assets S.A. (2014–2024)
Year-by-year debt coverage analysis for Biotechnology Assets S.A.. Check BST cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | €-73.85K | €8.17 Million | ▼ -290.7% |
| 2023 | 0.00x | €47.74K | €10.08 Million | ▲ +104.0% |
| 2022 | -0.12x | €-1.73 Million | €14.60 Million | ▼ -22.8% |
| 2021 | -0.10x | €-1.50 Million | €15.54 Million | ▼ -118.0% |
| 2020 | 0.54x | €8.79 Million | €16.37 Million | ▲ +401.6% |
| 2019 | -0.18x | €-15.16 Million | €85.11 Million | ▲ +20.6% |
| 2018 | -0.22x | €-13.02 Million | €58.04 Million | ▼ -1104.4% |
| 2017 | 0.02x | €213.49K | €9.56 Million | ▼ -93.4% |
| 2016 | 0.34x | €2.71 Million | €8.02 Million | ▲ +1447.8% |
| 2015 | 0.02x | €158.16K | €7.23 Million | ▲ +150.5% |
| 2014 | -0.04x | €-303.79K | €7.01 Million | — |